S
Susumu Kobayashi
Researcher at Beth Israel Deaconess Medical Center
Publications - 648
Citations - 23408
Susumu Kobayashi is an academic researcher from Beth Israel Deaconess Medical Center. The author has contributed to research in topics: Total synthesis & Epidermal growth factor receptor. The author has an hindex of 62, co-authored 629 publications receiving 21514 citations. Previous affiliations of Susumu Kobayashi include Chiba University & University of Tokyo.
Papers
More filters
Journal ArticleDOI
Transition-metal binding site of bleomycin. a synthetic analog capable of binding iron(ii) to yield an oxygen-sensitive complex
Masami Otsuka,M. Yoshida,Susumu Kobayashi,Masaji Ohno,Yukio Sugiura,Tomohisa Takita,Hamao Umezawa +6 more
Journal ArticleDOI
Patterns of care for non-small-cell lung cancer at an academic institution affiliated with a national cancer institute-designated cancer center.
Kim-Son H. Nguyen,Rachel A. Sanford,Mark S. Huberman,Michael A. Goldstein,Danielle M. McDonald,Mary Farquhar,Sidharta P. Gangadharan,Michael S. Kent,Gaetane Michaud,Adnan Majid,Stuart M. Berman,Joseph A. Aronovitz,Elena Nedea,Phillip M. Boiselle,David W. Cohen,Susumu Kobayashi,Daniel B. Costa +16 more
TL;DR: There was no significant correlation between evidence-based adherence status and the patient's age, sex, performance status, smoking history, ethnicity, or the treating physician, and data point toward the need for improved evidence- based use of resources in the third-line setting of stage IV NSCLC.
Journal ArticleDOI
Upregulation of FGF9 in Lung Adenocarcinoma Transdifferentiation to Small Cell Lung Cancer
Kota Ishioka,Hiroyuki Yasuda,Junko Hamamoto,Hideki Terai,Katsura Emoto,Tae Jung Kim,Shigemichi Hirose,Takashi Kamatani,Takashi Kamatani,Takashi Kamatani,Sachiyo Mimaki,Daisuke Arai,Keiko Ohgino,Tetsuo Tani,Keita Masuzawa,Tadashi Manabe,Taro Shinozaki,Akifumi Mitsuishi,Toshiki Ebisudani,Takahiro Fukushima,Mari Ozaki,Shinnosuke Ikemura,Ichiro Kawada,Katsuhiko Naoki,Katsuhiko Naoki,Morio Nakamura,Takashi Ohtsuka,Hisao Asamura,Katsuya Tsuchihara,Yuichiro Hayashi,Ahmed E. Hegab,Susumu Kobayashi,Takashi Kohno,Hideo Watanabe,David M. Ornitz,Tomoko Betsuyaku,Kenzo Soejima,Koichi Fukunaga +37 more
TL;DR: In this paper, an integrative omics analysis of paired tumor samples from a patient with transdifferentiated SCLC exhibited robust upregulation of FGF9 at the protein level in four of six (66.7%) paired samples.
Journal ArticleDOI
General development plan of surgical robotic systems
Journal ArticleDOI
Identification of myeloproliferative neoplasm drug agents via predictive simulation modeling: assessing responsiveness with micro-environment derived cytokines.
TL;DR: This study predictively identified two drug agents that reduce MPN cell viability via independent mechanisms that was prospectively validated and validated the use of this simulation based technology to prospectively determine such responses.